ENHERTU Granted Breakthrough Therapy Designation in U.S. for Patients with HER2 Low Metastatic Breast Cancer Read more
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity Read more
Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age Read more
Isleworth Healthcare Acquisition Corp. and Cytovia Therapeutics Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Empowering Natural Killer Cell Therapeutics to Fight Cancer Read more
Tremelimumab accepted under Priority Review in the US for patients with unresectable liver cancer in combination with Imfinzi Read more
Turnstone Biologics Announces TIL Therapy Research Collaboration with the University of Montreal Hospital Research Centre Read more
Veklury (Remdesivir) is First and Only Approved Treatment for Pediatric Patients Under 12 Years of Age with COVID-19 Read more